Flow State Investments, L.P. Horizon Therapeutics Public LTD CO Transaction History

Flow State Investments, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $5.6 Million - $6.54 Million	56,535 Added 89.17%	119,935 $13.9 Billion
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $1.39 Million - $1.62 Million	14,400 Added 29.39%	63,400 $6.52 Billion
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $3.11 Million - $3.29 Million	29,000 Added 145.0%	49,000 $5.35 Billion
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $1.25 Million - $2.28 Million	20,000 New	20,000 $2.28 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Flow State Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Flow State Investments, L.P. with notifications on news.